Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | QTX-2101 |
| Trade Name | |
| Synonyms | SY 2101|SY2101|SY-2101|QTX 2101|QTX2101|ORH-2014|ORH2014|ORH 2014 |
| Drug Descriptions |
QTX-2101 is an oral formulation of arsenic trioxide, which potentially induces tumor cell apoptosis (PMID: 40020161, NCI Drug Dictionary) |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C133720 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Arsenic trioxide + QTX-2101 | Arsenic trioxide QTX-2101 | 0 | 1 |
| QTX-2101 | QTX-2101 | 0 | 1 |
| QTX-2101 + Tretinoin | QTX-2101 Tretinoin | 0 | 1 |